
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.980 | 5.980 | 0.000 |
Shares | 93.750 | 93.750 | 0.000 |
Other | 0.270 | 0.270 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 36.168 | 21.978 |
Price to Book | 2.786 | 3.547 |
Price to Sales | 4.251 | 3.056 |
Price to Cash Flow | 11.909 | 11.512 |
Dividend Yield | 0.334 | 1.632 |
5 Years Earnings Growth | 3.781 | 11.269 |
Number of long holdings: 37
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Hansoh Pharmaceutical Group | KYG549581067 | 9.46 | 22.80 | +1.56% | |
Akeso Inc Ordinary Shares | - | 9.09 | - | - | |
Innovent Biologics | KYG4818G1010 | 7.99 | 50.65 | +1.30% | |
Sichuan Kelun Biotech | CNE1000062J1 | 5.58 | 316.00 | +0.32% | |
Boston Scientific | US1011371077 | 5.29 | 102.95 | +0.08% | |
Keymed Biosciences Inc | - | 4.92 | - | - | |
Hutchison China | KYG4672N1198 | 4.58 | 209.50 | -2.10% | |
Ascentage Pharma | KYG0519B1023 | 4.30 | 46.30 | +0.76% | |
Summit Therapeutics PLC | US86627T1088 | 3.75 | 24.610 | -2.57% | |
argenx ADR | US04016X1019 | 2.73 | 542.47 | -3.29% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
E Fund Blue Chip Selected Mixed | 38.91B | 4.49 | -6.04 | - | ||
E Fund CSI China Oversea Net 50 | 37B | 14.63 | 9.42 | - | ||
E Fund Consumer Sector | 18.94B | -3.70 | -2.80 | 8.94 | ||
E Fund SSE50 Index | 18.94B | -3.78 | -1.43 | 4.20 | ||
E Fund CSI300 ETF Feeder Fund | 18.77B | -3.65 | 0.36 | 0.17 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review